Clinical Scorecard: Comprehensive Analysis of Preclinical Research on Herbal Remedies for Attention-Deficit/Hyperactivity Disorder
At a Glance
Category
Detail
Condition
Key Mechanisms
Modulation of catecholaminergic neurotransmission by herbal remedies, activation of neurotrophic signaling pathways, suppression of proinflammatory mediators.
Target Population
Care Setting
Key Highlights
Herbal interventions showed improvements in ADHD-like behaviors, but safety outcomes were rarely reported.
Majority of studies relied on spontaneously hypertensive rat models, limiting generalizability.
Behavioral assessments focused primarily on hyperactivity, with insufficient attention to inattention and impulsivity.
Promising formulations include Long Mu Qing Xin mixture and An Shen Ding Zhi Ling, but methodological rigor was often lacking.
Guideline-Based Recommendations
Diagnosis
Management
Current treatments include stimulants (e.g., methylphenidate) and nonstimulants (e.g., atomoxetine), as well as behavioral therapies and psychoeducation.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Children, adolescents, and adults with ADHD.
Herbal medicines may offer alternative therapeutic options, but further research is needed.
Clinical Best Practices
Utilize diverse animal models in ADHD research, including those that assess inattention and impulsivity.
Implement rigorous methodological standards in preclinical studies, including randomization and blinding.
Conduct comprehensive behavioral assessments beyond hyperactivity, such as cognitive and emotional evaluations.
